Dual <scp>GIPR</scp> and <scp>GLP</scp> ‐ <scp>1R</scp> Agonist Tirzepatide Is Associated With Fewer Asthma Exacerbations in Adults With Obesity
Summary Tirzepatide use was associated with fewer asthma exacerbations in obese adults without prior exacerbations. Findings are limited to a selective asthma population and require validation in broader cohorts.
Authors
- Rawan Elkomi (ORCID: https://orcid.org/0000-0002-3707-544X)
- Syed Fahad Gillani
- Syona Mehta
- Miriam Michael
Institutions
- University of Maryland, Baltimore (US)
- Howard University (US)
Publication Details
- Journal
- Clinical & Experimental Allergy
- Published
- 2026-02-18
- DOI
- https://doi.org/10.1111/cea.70245
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00